GE HealthCare launches next-gen intraoperative ultrasound tech
26 Apr 2023
Acquisition
BK Medical, a subsidiary of GE HealthCare, developed the flagship intraoperative ultrasound imaging system. It designed bkActiv to deliver high-performance ultrasound guidance with a simplified, intuitive user experience for surgeons.
GE HealthCare acquired BK Medical for $1.45 billion in December 2021.
The system features an automatic, no-touch autogain and advanced algorithms to provide high-level image quality. This enables confident decision-making during surgical procedures, according to a news release. GE HealthCare says the system allows for minimal user interaction so surgeons can focus on their patients.
According to the company, bkActiv allows for detailed, real-time surgical visualization. The latest addition enables enhanced image quality for the prostate, kidney and bladder. It also features a sensitive color doppler to visualize and measure the speed and direction of blood flow during complex surgical procedures.
Features include True-Sense technology and a “Smart Button” that allows surgeons to operate the system with one hand. It also features an advanced transducer portfolio that includes robotic and laparoscopic transducers. The bkActiv platform offers an adjustable monitor and easy integration into a crowded operating room, too, GE HealthCare said.
“By expanding the bkActiv system, we are giving physicians the tools they need to provide precise treatment with the ability to see fine details in image guidance, which ultimately may allow for better outcomes for people who require urology, colorectal and pelvic floor procedures,” said Urvi Vyas, GM, surgical visualization & guidance, ultrasound at GE HealthCare, “We are proud to be the trusted partner for surgeons around the world given our long history of leadership in imaging and innovation.”
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.